Verified peer comparison

ISRG vs BSX

Intuitive Surgical, Inc. compared with Boston Scientific Corporation. This page compares both source-verified company profiles and does not introduce an unverified price target.

ISRG

Intuitive Surgical, Inc.

$189.43

Open: --
High: --
Low: --
Market Cap: --

Open stock research

BSX

Boston Scientific Corporation

$189.43

Open: --
High: --
Low: --
Market Cap: --

Open stock research

Company-specific comparison

Business exposure

ISRG: Health Care Equipment

BSX: Health Care Equipment

Upside lens

ISRG: Continued da Vinci and Ion procedure growth increases utilization and expands recurring instruments, accessories, and service demand. Growing da Vinci 5 placements can refresh the installed base, deepen customer adoption, and support higher system and recurring revenue over time. Expansion of the da Vinci and Ion installed bases increases the platform available for future procedures, services, and instruments and accessories revenue.

BSX: FARAPULSE adoption can expand electrophysiology procedure share and associated catheter demand. WATCHMAN and related structural-heart platforms can benefit from broader physician adoption and indications. A broad cadence of launches across cardiology, endoscopy and urology can sustain above-market procedure growth.

Risk lens

ISRG: Tariffs are expected to reduce gross margin, and additional measures beyond those assumed in guidance could have a material financial effect. New systems and indications require regulatory clearances, while expanding robotic-surgery competition could pressure placements, pricing, or utilization. A large share of systems placed under operating leases increases exposure to customer utilization and can delay revenue recognition relative to outright sales.

BSX: Trial outcomes, approval delays or safety signals can slow adoption of important growth platforms. Acquisitions can create integration costs, leverage and execution demands across a rapidly expanding portfolio. Large rivals and new technologies can pressure pricing, physician loyalty and market share.